Clinical Trial Update: A Study of Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract [Phase 2]

View source ↗

Summary

A Phase 2 study of Enfortumab Vedotin for urothelial carcinoma of the upper urinary tract is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Upper Tract Urothelial Carcinoma
• Urothelial Carcinoma

Drugs mentioned

• Enfortumab Vedotin (enfortumab vedotin)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Urothelial Carcinoma | Phase 2 | Status: RECRUITING